Literature DB >> 23848563

Vascular smooth muscle cell phenotype is defined by Ca2+-dependent transcription factors.

Olga Kudryavtseva1, Christian Aalkjaer, Vladimir V Matchkov.   

Abstract

Ca(2+) is an important second messenger in vascular smooth muscle cells (VSMCs). Therefore, VSMCs exercise tight control of the intracellular Ca(2+) concentration ([Ca(2+)]i) by expressing a wide repertoire of Ca(2+) channels and transporters. The presence of several pathways for Ca(2+) influx and efflux provides many possibilities for controlling [Ca(2+)]i in a spatial and temporal manner. Intracellular Ca(2+) has a dual role in VSMCs; first, it is necessary for VSMC contraction; and, second, it can activate multiple transcription factors. These factors are cAMP response element-binding protein, nuclear factor of activated T lymphocytes, and serum response factor. Furthermore, it was recently reported that the C-terminus of voltage-dependent L-type Ca(2+) calcium channels can regulate transcription in VSMCs. Transcription regulation in VSMCs modulates the expression patterns of genes, including genes coding for contractile and cytoskeleton proteins, and those promoting proliferation and cell growth. Depending on their gene expression, VSMCs can exist in different functional states or phenotypes. The majority of healthy VSMCs show a contractile phenotype, characterized by high contractile ability and a low proliferative rate. However, VSMCs can undergo phenotypic modulation with different physiological and pathological stimuli, whereby they start to proliferate, migrate, and synthesize excessive extracellular matrix. These events are associated with injury repair and angiogenesis, but also with the development of cardiovascular pathologies, such as atherosclerosis and hypertension. This review discusses the currently known Ca(2+)-dependent transcription factors in VSMCs, their regulation by Ca(2+) signalling, and their role in the VSMC phenotype.
© 2013 FEBS.

Entities:  

Keywords:  CREB; calcium (Ca2+) signalling; nuclear factor of activated T lymphocytes (NFAT); transcription; vascular smooth muscle cell phenotype

Mesh:

Substances:

Year:  2013        PMID: 23848563     DOI: 10.1111/febs.12414

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  35 in total

Review 1.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

2.  TGF-β1 induces human aortic vascular smooth muscle cell phenotype switch through PI3K/AKT/ID2 signaling.

Authors:  Shui-Bo Zhu; Jian Zhu; Zi-Zi Zhou; Er-Ping Xi; Rong-Ping Wang; Yu Zhang
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

3.  Up-regulation of Store-operated Ca2+ Entry and Nuclear Factor of Activated T Cells Promote the Acinar Phenotype of the Primary Human Salivary Gland Cells.

Authors:  Shyh-Ing Jang; Hwei Ling Ong; Xibao Liu; Ilias Alevizos; Indu S Ambudkar
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

4.  CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.

Authors:  Wei Zhong; Bo Li; Ping Yang; Rui Chen; Cuiping Wang; Zhongqun Wang; Chen Shao; Wei Yuan; Jinchuan Yan
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

5.  A bioinformatic and computational study of myosin phosphatase subunit diversity.

Authors:  Rachael P Dippold; Steven A Fisher
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

Review 6.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

7.  Gax regulates human vascular smooth muscle cell phenotypic modulation and vascular remodeling.

Authors:  Hui Zheng; Zhenlei Hu; Xinming Zhai; Yongyi Wang; Jidong Liu; Weijun Wang; Song Xue
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 8.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

Review 9.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

10.  LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Regulates Smooth Muscle Contractility by Modulating Ca2+ Signaling and Expression of Cytoskeleton-Related Proteins.

Authors:  Dianaly T Au; Zhekang Ying; Erick O Hernández-Ochoa; William E Fondrie; Brian Hampton; Mary Migliorini; Rebeca Galisteo; Martin F Schneider; Alan Daugherty; Debra L Rateri; Dudley K Strickland; Selen C Muratoglu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.